bf/NASDAQ:TNXP_icon.jpeg

COM:TONIXPHARMA

Tonix Pharmaceuticals

  • Stock

Last Close

0.19

21/11 18:29

Market Cap

6.10M

Beta: -

Volume Today

63.46M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
7.77M
-
cost of revenue
10.89M
-
27.66M
154.00%
48.16M
74.15%
38.97M
19.09%
21.29M
45.36%
26.32M
23.63%
28.83M
9.52%
50.51M
75.22%
92.31M
82.76%
112.09M
21.43%
4.74M
95.77%
gross profit
-10.89M
-
-27.66M
154.00%
-48.16M
74.15%
-38.97M
19.09%
-21.29M
45.36%
-26.32M
23.63%
-28.83M
9.52%
-50.51M
75.22%
-92.31M
82.76%
-112.09M
21.43%
3.03M
102.70%
selling and marketing expenses
general and administrative expenses
6.24M
-
9.04M
44.90%
12.66M
40.04%
10.44M
17.55%
7.95M
23.83%
8.76M
10.25%
10.64M
21.36%
14.35M
34.96%
23.47M
63.54%
30.21M
28.72%
34.75M
15.02%
selling general and administrative expenses
6.24M
-
9.04M
44.90%
12.66M
40.04%
10.44M
17.55%
7.95M
23.83%
8.76M
10.25%
10.64M
21.36%
14.35M
34.96%
23.47M
63.54%
30.21M
28.72%
34.75M
15.02%
research and development expenses
4.65M
-
18.62M
300.37%
35.50M
90.71%
28.53M
19.63%
13.34M
53.24%
17.56M
31.60%
18.19M
3.61%
36.16M
98.75%
68.84M
90.39%
81.88M
18.94%
86.66M
5.84%
other expenses
cost and expenses
10.89M
-
27.66M
154.00%
48.16M
74.15%
38.97M
19.09%
21.29M
45.36%
26.32M
23.63%
28.83M
9.52%
50.51M
75.22%
92.31M
82.76%
112.09M
21.43%
126.15M
12.54%
operating expenses
10.89M
-
27.66M
154.00%
48.16M
74.15%
38.97M
19.09%
21.29M
45.36%
26.32M
23.63%
28.83M
9.52%
50.51M
75.22%
92.31M
82.76%
112.09M
21.43%
121.41M
8.31%
interest expense
4K
-
-7.91M
-
ebitda
-10.89M
-
-27.66M
154.00%
-48.16M
74.15%
-38.97M
19.09%
-21.29M
45.36%
-26.32M
23.63%
-28.83M
9.52%
-50.51M
75.22%
-92.31M
82.76%
-112.09M
21.43%
-118.38M
5.61%
operating income
-10.89M
-
-27.66M
154.00%
-48.16M
74.15%
-38.97M
19.09%
-21.29M
45.36%
-26.32M
23.63%
-28.83M
9.52%
-50.51M
75.22%
-92.31M
82.76%
-112.09M
21.43%
-118.38M
5.61%
depreciation and amortization
17K
-
36K
111.76%
161K
347.22%
206K
27.95%
70K
66.02%
54K
22.86%
26K
51.85%
27K
3.85%
50K
85.19%
1.25M
2,406%
total other income expenses net
4K
-
40K
900%
108K
170%
127K
17.59%
168K
32.28%
233K
38.69%
210K
9.87%
48K
77.14%
25K
47.92%
1.87M
7,392%
1.72M
8.06%
income before tax
-10.88M
-
-27.62M
153.73%
-48.05M
74.01%
-38.84M
19.17%
-21.12M
45.62%
-26.09M
23.51%
-28.62M
9.69%
-50.46M
76.33%
-92.29M
82.88%
-110.22M
19.43%
-116.66M
5.84%
income tax expense
-17K
-
-36K
111.76%
-161K
347.22%
-206K
27.95%
-70K
66.02%
233K
432.86%
-236K
201.29%
-75K
68.22%
-75K
0%
4.79M
6,481.33%
net income
-10.88M
-
-27.62M
153.73%
-48.05M
74.01%
-38.84M
19.17%
-21.12M
45.62%
-26.09M
23.51%
-28.38M
8.79%
-50.39M
77.54%
-92.21M
83.00%
-115.00M
24.72%
-116.66M
1.44%
weighted average shs out
29
-
54
86.21%
94
74.07%
195
107.45%
391
100.51%
1.63K
315.60%
8.04K
394.89%
472.96K
5,781.10%
1.82M
285.23%
35.74M
1,861.56%
17.04B
47,577.00%
weighted average shs out dil
29
-
54
86.21%
94
74.07%
195
107.45%
391
100.51%
1.63K
315.60%
8.04K
394.89%
472.96K
5,781.10%
1.82M
285.23%
35.74M
1,861.56%
17.04B
47,577.00%
eps
-375.31K
-
-511.41K
36.26%
-511.21K
0.04%
-199.19K
61.04%
-54.02K
72.88%
-16.05K
70.28%
-3.53K
78.02%
-106.54
96.98%
-50.61
52.50%
-3.22
93.64%
-0.01
99.79%
epsdiluted
-375.31K
-
-511.41K
36.26%
-511.21K
0.04%
-199.19K
61.04%
-54.02K
72.88%
-16.05K
70.28%
-3.53K
78.02%
-106.54
96.98%
-50.61
52.50%
-3.22
93.64%
-0.01
99.79%

All numbers in (except ratios and percentages)